A method for crystallizing doxorubicin hydrochloride from an aqueous solution thereof which comprises crystallizing under a condition comprising a temperature of 40 DEG C or higher, and an aggregate of doxorubicin hydrochloride crystals having excellent solubility particularly in water.
